Loading
A phase 2 trial of Aminoglutethimide in Prostate cancer, run by H. Lee Moffitt Cancer Center and Research Institute, recorded as terminated on the registry.
A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer is a phase 2 interventional study registered as NCT00006371 by H. Lee Moffitt Cancer Center and Research Institute, with 2 participants recorded, started 2000-05 and due to reach its primary completion in 2001-12. Interventions recorded: aminoglutethimide, ketoconazole, therapeutic hydrocortisone. Conditions recorded: Prostate Cancer.
Linked to the drug Aminoglutethimide because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Shares Prostate cancer and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/